Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Vor Bio to Participate in the Wedbush PacGrow Healthcare Conference By: Vor Biopharma via GlobeNewswire August 01, 2023 at 08:00 AM EDT CAMBRIDGE, Mass., Aug. 01, 2023 (GLOBE NEWSWIRE) -- Vor Bio (Nasdaq: VOR), a clinical-stage cell and genome engineering company, will host in-person 1x1 investor meetings at the 2023 Wedbush PacGrow Healthcare Conference. Wedbush PacGrow Healthcare Conference1x1 Investor Meetings: August 8-9, 2023Location: Lotte Palace Hotel, New York, NY About Vor BioVor Bio is a clinical-stage cell and genome engineering company that aims to change the standard of care for patients with blood cancers by engineering hematopoietic stem cells to enable targeted therapies post-transplant. For more information, visit: www.vorbio.com. Contact: Media & InvestorsSarah Spencer +1 857-242-6076sspencer@vorbio.com Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
Vor Bio to Participate in the Wedbush PacGrow Healthcare Conference By: Vor Biopharma via GlobeNewswire August 01, 2023 at 08:00 AM EDT CAMBRIDGE, Mass., Aug. 01, 2023 (GLOBE NEWSWIRE) -- Vor Bio (Nasdaq: VOR), a clinical-stage cell and genome engineering company, will host in-person 1x1 investor meetings at the 2023 Wedbush PacGrow Healthcare Conference. Wedbush PacGrow Healthcare Conference1x1 Investor Meetings: August 8-9, 2023Location: Lotte Palace Hotel, New York, NY About Vor BioVor Bio is a clinical-stage cell and genome engineering company that aims to change the standard of care for patients with blood cancers by engineering hematopoietic stem cells to enable targeted therapies post-transplant. For more information, visit: www.vorbio.com. Contact: Media & InvestorsSarah Spencer +1 857-242-6076sspencer@vorbio.com
CAMBRIDGE, Mass., Aug. 01, 2023 (GLOBE NEWSWIRE) -- Vor Bio (Nasdaq: VOR), a clinical-stage cell and genome engineering company, will host in-person 1x1 investor meetings at the 2023 Wedbush PacGrow Healthcare Conference. Wedbush PacGrow Healthcare Conference1x1 Investor Meetings: August 8-9, 2023Location: Lotte Palace Hotel, New York, NY About Vor BioVor Bio is a clinical-stage cell and genome engineering company that aims to change the standard of care for patients with blood cancers by engineering hematopoietic stem cells to enable targeted therapies post-transplant. For more information, visit: www.vorbio.com. Contact: Media & InvestorsSarah Spencer +1 857-242-6076sspencer@vorbio.com